Orthopedic Biomaterials Market worth $24.86 billion by 2030
The report "Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) - Forecast to 2030" is projected to grow from USD 16.95 billion in 2025 and to reach USD 24.86 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period.
Browse 908 market data Tables and 50 Figures spread through 663 Pages and in-depth TOC on "Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/orthopedic-biomaterials-market-221903530.html
The orthopedic biomaterials market is experiencing growth, driven by several key factors, including the broad adoption across medical devices, drug delivery systems, and tissue repair applications, as well as cost advantages compared to metallic and ceramic biomaterials in high-volume applications.
The stainless steel segment accounted for the largest share of the metallic biomaterials market, by type, in 2024.
By metallic biomaterials type, the market is segmented into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, silver, gold, magnesium, and other metallic biomaterials. The stainless steel segment accounted for the largest share of the orthopedic biomaterials market in 2024, due to its application in trauma fixation products such as plates, screws, rods, and pins, where strength, reliability, and economy are key considerations. Stainless steel is renowned for its strength, corrosion resistance, and ease of manufacture, making it a suitable material for high-volume orthopedic applications. Also, it has a history of successful usage and widespread acceptance among orthopedic manufacturers and hospitals.
The knee replacement segment is projected to register the fastest growth during the forecast period.
By joint replacement application, the market is segmented into knee replacement, hip replacement, shoulder replacement, and other joint replacement procedures. Knee replacement has emerged as the fastest-growing market for orthopedic biomaterials. The reason for this growth is a substantial increase in knee arthroplasty procedures, driven by an aging population, rising obesity cases, and older individuals seeking an active lifestyle. The adoption of PMMA bone cement, UHMWPE, and PEEK bearing surfaces, as well as metallic implants, in knee procedures is another factor contributing to market growth. Moreover, an increase in life expectancy and technological advancements in knee implants are leading to a rise in revision procedures
North America accounted for the largest regional share of the orthopedic biomaterials market in 2024.
The market for orthopedic biomaterials is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the largest share of the orthopedic biomaterials market in 2024. This can be attributed to the high volumes of joint replacements and spine procedures, strong reimbursement, and the rapid adoption of premium implant technologies. Additional growth drivers include the presence of leading orthopedic OEMs and raw material suppliers, intensive R&D and clinical trial activity in bioresorbable and smart biomaterials, and a well-developed hospital infrastructure that supports complex arthroplasty and trauma care.
Key players in the orthopedic biomaterials market include Celanese Corporation (US), Carpenter Technology Corporation (US), Evonik Industries AG (Germany), DSM (Netherlands), Corbion NV (Netherlands), CoorsTek Inc (US), Berkeley Advanced Materials (US), and CAM Bioceramics B.V. (Netherlands)
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Orthopedic Biomaterials Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
